Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Capital Employed (2022 - 2026)

HeartSciences filings provide 5 years of Return on Capital Employed readings, the most recent being 311.08% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 4881.0% to 311.08% in Q1 2026 year-over-year; TTM through Jan 2026 was 311.08%, a 4881.0% decrease, with the full-year FY2025 number at 264.34%, down 12854.0% from a year prior.
  • Return on Capital Employed hit 311.08% in Q1 2026 for HeartSciences, down from 177.18% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 554.21% in Q4 2023 to a low of 662.81% in Q2 2025.
  • Median Return on Capital Employed over the past 5 years was 262.27% (2025), compared with a mean of 232.32%.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 86370bps in 2023 and later crashed -71368bps in 2024.
  • HeartSciences' Return on Capital Employed stood at 309.49% in 2022, then surged by 279bps to 554.21% in 2023, then plummeted by -129bps to 159.47% in 2024, then fell by -11bps to 177.18% in 2025, then plummeted by -76bps to 311.08% in 2026.
  • The last three reported values for Return on Capital Employed were 311.08% (Q1 2026), 177.18% (Q4 2025), and 352.01% (Q3 2025) per Business Quant data.